ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.495
0.00%
Bitcoin
98,361.27
0.16%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kiromic BioPharma Inc (KRBP)

  7. Kiromic BioPharma Inc (KRBP) News

KRBP

Kiromic BioPharma (KRBP)

Kiromic BioPharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KRBP
DateTimeSourceHeadlineSymbolCompany
09/19/20244:30PMBusiness WireKiromic BioPharma Activates the University of Arizona Cancer Center as the Fifth Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 TrialNASDAQ:KRBPKiromic BioPharma Inc
09/19/20248:00AMBusiness WireKiromic BioPharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee’s Unanimous RecommendationNASDAQ:KRBPKiromic BioPharma Inc
08/21/20244:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
08/14/20248:00AMBusiness WireKiromic BioPharma’s Deltacel Receives FDA Fast Track DesignationNASDAQ:KRBPKiromic BioPharma Inc
08/09/20243:04PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRBPKiromic BioPharma Inc
08/09/20248:00AMBusiness WireKiromic BioPharma Provides Update on Part 1 of the Deltacel-01 TrialNASDAQ:KRBPKiromic BioPharma Inc
08/01/20248:00AMBusiness WireKiromic BioPharma Reports 20% Tumor Size Reduction at Eight Months in First Patient Enrolled in Deltacel-01NASDAQ:KRBPKiromic BioPharma Inc
07/18/20248:00AMBusiness WireKiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion PhaseNASDAQ:KRBPKiromic BioPharma Inc
06/28/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
06/27/20245:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
06/20/20248:00AMBusiness WireKiromic BioPharma Provides Updates on its Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
06/13/20246:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
06/13/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
06/12/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
06/12/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
06/07/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
06/06/20248:00AMBusiness WireKiromic BioPharma Reports Six-Month Results from First Patient Enrolled in Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
06/04/20245:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
05/29/20248:00AMBusiness WireKiromic BioPharma Reports Favorable Results at Six Weeks from Fourth Patient in Deltacel-01 Clinical TrialNASDAQ:KRBPKiromic BioPharma Inc
05/22/20245:03PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRBPKiromic BioPharma Inc
05/21/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
05/20/20245:00PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:KRBPKiromic BioPharma Inc
05/20/20248:00AMBusiness WireKiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial SiteNASDAQ:KRBPKiromic BioPharma Inc
05/20/20246:29AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:KRBPKiromic BioPharma Inc
05/17/20244:43PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:KRBPKiromic BioPharma Inc
04/24/20248:08AMBusiness WireKiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three PatientsNASDAQ:KRBPKiromic BioPharma Inc
04/19/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
04/10/20244:30PMEdgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:KRBPKiromic BioPharma Inc
04/05/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
04/02/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRBPKiromic BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:KRBP

Your Recent History

USOTC
GDVM
Global Developments (PK)
USOTC
TWOH
Two Hands (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
AFFU
Affluence (PK)
USOTC
RNVA
Rennova Health (CE)
COIN
XRPUSD
Ripple
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
RDGL
Vivos (QB)
NASDAQ
AMRN
Amarin
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
TSLA
Tesla
NASDAQ
LWLG
Lightwave Logic
USOTC
FNMA
Fannie Mae (QB)
USOTC
HMBL
HUMBL (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads